benefits of tirzepatide over semaglutide Comparative safety and side effects and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide hits two receptors. Semaglutide

Each patient receives a customized titration schedule: most users begin at a low dose and increase gradually over weeks to minimize gastrointestinal side effects while maximizing weight loss

1 In summary, in both study populations, a weight loss plateau was not observed, again indicating the potential for further weight loss beyond 52 weeks

Fauconnier J, Lanner JT, Zhang SJ, et al

When you come in for your consultation, well decide on your best option for treatment

Body weight among the four groups (control, GCGR mAb, GCGR mAb+FGF21 nAb and FGF21 nAb treatments) was comparable (Fig

An important note: Zepbound has been approved for sleep apnea and Wegovy for cardiovascular risk, with weight loss as a side benefit